Reasons for delay in cataract surgery in patients with advanced cataracts during the COVID-19 pandemic.

Advanced cataracts during COVID-19 pandemic barriers for cataract surgery during pandemic delay in cataract surgery

Journal

Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376

Informations de publication

Date de publication:
06 2022
Historique:
entrez: 1 6 2022
pubmed: 2 6 2022
medline: 7 6 2022
Statut: ppublish

Résumé

To analyze the reasons for delay in cataract surgery in patients with advanced cataracts during the COVID-19 pandemic. This was a prospective, cross-sectional, multicenter questionnaire study which included patients with mature cataract, nuclear sclerotic cataract grade IV, and cataracts with best corrected visual acuity (BCVA) <5/60, during the COVID-19 pandemic from December 2020 to April 2021. Reasons for delay in presentation to the hospital were analyzed. One thousand four hundred seventy two patients were recruited with advanced cataracts. Absence of ophthalmic care nearby (44.2%), lack of awareness regarding elective surgeries (42.6%), lack of public transportation (37%), fear of contracting COVID-19 (23.4%), and waiting for outreach camps (20.4%) were found to be the reasons behind the delay in cataract surgery. 53.7% of the patients had worsening of defective vision and 55.3% of them had difficulty in carrying out activities of family living. 30.8% of the patients faced difficulty in commuting and 8.4% of the patients suffered a fall during this pandemic due to worsening of the visual acuity. The lockdown imposed during the pandemic has created a significant backlog of patients who are progressing to advanced cataracts due to lack of ophthalmic care nearby, lack of awareness regarding elective surgeries, lack of public transportation, and no outreach camps. Proactive measures to deal with this backlog are of utmost need to prevent blindness due to cataract.

Identifiants

pubmed: 35648002
pii: IndianJOphthalmol_2022_70_6_2153_346174
doi: 10.4103/ijo.IJO_544_22
pmc: PMC9359252
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2153-2157

Déclaration de conflit d'intérêts

None

Références

Indian J Ophthalmol. 2020 Jul;68(7):1269-1276
pubmed: 32587150
BMJ Open. 2021 Jan 19;11(1):e043590
pubmed: 33468529
Br J Ophthalmol. 2014 May;98(5):619-28
pubmed: 24518073
Curr Opin Ophthalmol. 2011 Jan;22(1):4-9
pubmed: 21107260
Arch Ophthalmol. 1995 Oct;113(10):1337-40
pubmed: 7575272
Ophthalmic Epidemiol. 2007 May-Jun;14(3):112-8
pubmed: 17613845
Br J Ophthalmol. 2004 Oct;88(10):1237-41
pubmed: 15377541
Br J Ophthalmol. 2014 May;98(5):586-91
pubmed: 24407561
Am J Ophthalmol. 2021 Jul;227:53-65
pubmed: 33781768
Br J Ophthalmol. 2014 May;98(5):599-604
pubmed: 24390167
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):319-323
pubmed: 32298984
Bull World Health Organ. 1999;77(2):104-9
pubmed: 10083707
Br J Ophthalmol. 2014 May;98(5):592-8
pubmed: 24457361
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):303-310
pubmed: 32298981
Indian J Ophthalmol. 2007 Mar-Apr;55(2):133-6
pubmed: 17322604
Indian J Ophthalmol. 2020 Feb;68(2):291-293
pubmed: 31957710

Auteurs

Rajesh Vedachalam (R)

Senior Resident, General Ophthalmology, Aravind Eye Hospital, Pondicherry, India.

Kumaresan Yamini (K)

Glaucoma Services, Aravind Eye Hospital, Pondicherry, India.

Rengaraj Venkatesh (R)

Glaucoma Services, Aravind Eye Hospital, Pondicherry, India.

Narendran Kalpana (N)

Cataract Services, Aravind Eye Hospital, Coimbatore, Tamil Nadu, India.

Chandrashekaran Shivkumar (C)

Cataract Services, Aravind Eye Hospital, Tirunelveli, Tamil Nadu, India.

Madhu Shekhar (M)

Cataract Services, Aravind Eye Hospital, Madurai, Tamil Nadu, India.

Aravind Haripriya (A)

Cataract Services, Aravind Eye Hospital, Chennai, Tamil Nadu, India.

Ravilla Sathya (R)

Pediatric Ophthalmology and Adult Strabismus Services, Sri Venkateshwara Aravind Eye Hospital, Tirupati, Andhra Pradesh, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH